Anika Therapeutics (ANIK) EBITDA (2010 - 2026)
Anika Therapeutics (ANIK) EBITDA from Jun 30, 2010 to Mar 31, 2026. The TTM Anika Therapeutics (ANIK) EBITDA is -$6.85M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
Anika Therapeutics (ANIK) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +1914.71% |
| 5 Years TTM | -25.21% |
Annual EBITDA change of Anika Therapeutics (ANIK)
| Year | EBITDA | Change |
|---|---|---|
| 2026 | -$4.08M | -28.17% |
| 2025 | -$5.68M | -419.10% |
| 2024 | $1.78M | -75.55% |
| 2023 | $7.28M | -29.80% |
| 2022 | $10M | +13.96% |
| 2021 | $9.10M | -140.92% |
| 2020 | -$22M | -156.72% |
| 2019 | $39M | +41.76% |
| 2018 | $28M | -44.70% |
| 2017 | $50M | -7.95% |
| 2016 | $54M | +4.68% |
| 2015 | $52M | -21.53% |
| 2014 | $66M | +76.97% |
| 2013 | $37M | +54.21% |
| 2012 | $24M | +34.89% |
| 2011 | $18M | +65.47% |
| 2010 | $11M | +57.85% |
| 2009 | $6.88M | N/A |
Comparison Anika Therapeutics (ANIK) five years EBITDA CAGR with competitors
Anika Therapeutics (ANIK) five years EBITDA CAGR is -25.20%.